This project within the P20 application is: Neural Effects of Chronic Cannabis Exposure in HumanAdolescents. The overall hypothesis is that dysregulation of frontal cortex function by cannabis use impairsexecutive cognitive function, thereby increasing vulnerability to cannabis dependence. As adolescence ischaracterized by ongoing brain development, this may be a particularly vulnerable period. Thus, brainfunctioning will be characterized in human adolescents ages 15-17 to evaluate brain and behavioralabnormalities associated with chronic cannabis use using neuropsychological testing and functionalmagnetic resonance imaging (fMRI).Cannabis users (n=30) and demographically similar normal controls (n=30) will be free from psychiatric orneurological problems or substantial other substance involvement, and users will have >200 lifetimesexposures to cannabis. All youths will receive (1) neuropsychological testing focused on inhibition, verballearning, and other executive functions as well as (2) fMRI during an inhibitory task previously shown toactivate prefrontal regions, and during administration of Cambridge Neuropsychological Test AutomatedBattery (CANTAB) tasks that involve frontal regions and have non-human primate analogs. Then, youths willundergo a 28-day monitored abstinence period involving coming to the research site 9 times in 28 days forprovision of an observed sample for urine drug screening. Each week, a brief battery of repeatable CANTABtests will be administered, and subjective ratings of cannabis withdrawal, mood state, cortisol, and sleepquality will be collected. On the 27 day, subjects will repeat the full neuropsychological battery, and on the28th day, participants will be given the same fMRI protocol.MANCOVA will contrast test performance and prefrontal brain response between groups and across time,controlling for potential confounds. To evaluate developmental differences in duration and chronicity ofcannabis exposure, data will be contrasted directly with similar measures administered in Dr. Mason'sproject within this P20 application. Results will also be compared to those of adolescent non-human primatesand rodents from the Center projects of Drs. Taffe and Parsons, respectively. Together, these projects andthe infrastructure and training of the Center will help identify mechanisms for vulnerability to cannabisdependence, and characterize the potential neurotoxic abnormalities associated with chronic heavy cannabisuse in youth.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory Grants (P20)
Project #
1P20DA024194-01
Application #
7390048
Study Section
Special Emphasis Panel (ZDA1-MXS-M (19))
Project Start
2007-09-01
Project End
2011-06-30
Budget Start
2007-09-30
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$162,767
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Taffe, Michael A; Creehan, Kevin M; Vandewater, Sophia A (2015) Cannabidiol fails to reverse hypothermia or locomotor suppression induced by ?(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol 172:1783-91
Taffe, M A (2015) Drug abuse scientists should use social media to engage the public because their primary translational product is information. Drug Alcohol Depend 154:315-9
Irimia, Cristina; Polis, Ilham Y; Stouffer, David et al. (2015) Persistent effects of chronic ?9-THC exposure on motor impulsivity in rats. Psychopharmacology (Berl) 232:3033-43
Jacobus, Joanna; Squeglia, Lindsay M; Sorg, Scott F et al. (2014) Cortical thickness and neurocognition in adolescent marijuana and alcohol users following 28 days of monitored abstinence. J Stud Alcohol Drugs 75:729-43
Hanson, Karen L; Thayer, Rachel E; Tapert, Susan F (2014) Adolescent marijuana users have elevated risk-taking on the balloon analog risk task. J Psychopharmacol 28:1080-7
Wright Jr, M Jerry; Vandewater, Sophia A; Taffe, Michael A (2013) Cannabidiol attenuates deficits of visuospatial associative memory induced by ?(9) tetrahydrocannabinol. Br J Pharmacol 170:1365-73
Wetherill, Reagan; Tapert, Susan F (2013) Adolescent brain development, substance use, and psychotherapeutic change. Psychol Addict Behav 27:393-402
Mahmood, O M; Goldenberg, D; Thayer, R et al. (2013) Adolescents' fMRI activation to a response inhibition task predicts future substance use. Addict Behav 38:1435-41
Wright Jr, M J; Vandewater, S A; Parsons, L H et al. (2013) ?(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques. Neuroscience 235:51-8
Taffe, M A (2012) ?9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys. Neuroscience 201:125-33

Showing the most recent 10 out of 35 publications